Chemokine (C-C Motif) Receptor 9 (CCR9) ELISA Kits

The protein encoded by CCR9 is a member of the beta chemokine receptor family. Additionally we are shipping Chemokine (C-C Motif) Receptor 9 Antibodies (246) and Chemokine (C-C Motif) Receptor 9 Proteins (4) and many more products for this protein.

list all ELISA KIts Gene Name GeneID UniProt
Anti-Mouse CCR9 CCR9 59289 O08707
CCR9 1238 O00590
Anti-Rat CCR9 CCR9 282832  
How to order from antibodies-online
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Order online

Top Chemokine (C-C Motif) Receptor 9 ELISA Kits at

Showing 1 out of 1 products:

Catalog No. Reactivity Sensitivity Range Images Quantity Supplier Delivery Price Details
Human 5.8 pg/mL 23.5-1500 pg/mL Typical standard curve 96 Tests Log in to see 15 to 18 Days

More ELISA Kits for Chemokine (C-C Motif) Receptor 9 Interaction Partners

Mouse (Murine) Chemokine (C-C Motif) Receptor 9 (CCR9) interaction partners

  1. CCR9 and CCL25 (show CCL25 ELISA Kits) expressions are induced in the early stages of airway inflammation and they have an important role modulating eosinophils and lymphocytes recruitment at the first stages of inflammatory process

  2. CCR9 and Integrin-beta7 expression has a differential effect on graft fate during acute graft-versus-host disease (GVHD) of the liver depending on the GVHD target tissue.

  3. data indicate that in addition to acting as a gut (show GUSB ELISA Kits)-homing molecule, CCR9 signaling shapes immune responses by inhibiting Treg cell development

  4. Data suggest that blocking CC chemokine receptor (show CCR1 PLURAL_@9243@) 9 (CCR9) may represent a novel safe therapy for rheumatoid arthritis (RA).

  5. activation of Notch1 (show NOTCH1 ELISA Kits) has a dominant-negative effect on Ccr9 transcription and that Notch1 (show NOTCH1 ELISA Kits) and E proteins control the dynamic expression of Ccr9 during T cell development.

  6. ACKR2 can regulate fetal (show CCL1 ELISA Kits) growth, placental structure, and neonatal mortality in mice.

  7. Further examination revealed that proximity of pro-lymphangiogenic macrophages to developing lymphatic vessel surfaces is increased in ACKR2-deficient mice and reduced in CCR2-deficient mice.

  8. some cells, including plasmacytoid dendritic cells, can express both CCR2 (show CCR2 ELISA Kits) and ACKR2; that Ly6C(high) monocytes have particularly strong CCL2 (show CCL2 ELISA Kits)-scavenging potential in vitro and in vivo; and that CCR2 (show CCR2 ELISA Kits) is a much more effective CCL2 (show CCL2 ELISA Kits) scavenger than ACKR2.

  9. CCR9/CCL25 (show CCL25 ELISA Kits) is involved in acute skin transplantation rejection and anti-CCL25 (show CCL25 ELISA Kits) strategies might be useful in preventing acute rejection.

  10. Accumulated CD11b (show ITGAM ELISA Kits)(+) macrophages are critical for activating hepatic stellate cells through the CCR9/CCL25 (show CCL25 ELISA Kits) axis and therefore promote liver fibrosis.

Human Chemokine (C-C Motif) Receptor 9 (CCR9) interaction partners

  1. this study showed that CCR7 (show CCR7 ELISA Kits) are overexpressed in CD4 (show CD4 ELISA Kits)(-) CD8 (show CD8A ELISA Kits)(-) thymocytes of myasthenia gravis patients.

  2. Results indicated that the expression levels of CCR9 in lesional skin may be a useful biologic marker of the clinical efficacy of infliximab therapy in psoriasis patients.

  3. Xray crystal structure of the CCR9 receptor in complex with vercirnon at 2.8 A resolution

  4. that CCL25 (show CCL25 ELISA Kits)/CCR9 signal may provide cancer cells with chemotactic abilities through influencing several epithelial-mesenchymal transitionmarkers

  5. Studies indicate important roles played by chemokine ligand 25 (CCL25 (show CCL25 ELISA Kits))/chemokine receptor (show CCR1 ELISA Kits) 9 (CCR9) in tumorigenesis, tumor chemoresistance and metastasis.

  6. CCR9 and Integrin-beta7 expression has a differential effect on graft fate during acute graft-versus-host disease (GVHD) of the liver depending on the GVHD target tissue.

  7. CCR9 mRNA and protein levels were significantly increased in the nasopharyngeal carcinoma group compared with the control group.

  8. CCR9-CCL25 (show CCL25 ELISA Kits) interaction promoted proliferation and suppressed apoptosis of non-small cell lung cancer cells by activating the PI3K (show PIK3CA ELISA Kits)/Akt (show AKT1 ELISA Kits) pathway.

  9. CCR9 could be beneficial in predicting lymph node metastasis, and it might act as a novel prognostic biomarker for lung adenocarcinoma.

  10. We also show that primary tumors can be modeled in immunocompetent mice by microinjecting CCR9-expressing cancer cell lines into early-stage mouse blastocysts, which induces central immune tolerance

Chemokine (C-C Motif) Receptor 9 (CCR9) Antigen Profile

Antigen Summary

The protein encoded by this gene is a member of the beta chemokine receptor family. It is predicted to be a seven transmembrane protein similar to G protein-coupled receptors. Chemokines and their receptors are key regulators of the thymocytes migration and maturation in normal and inflammation conditions. The specific ligand of this receptor is CCL25. It has been found that this gene is differentially expressed by T lymphocytes of small intestine and colon, suggested a role in the thymocytes recruitment and development that may permit functional specialization of immune responses in different segment of the gastrointestinal tract. This gene is mapped to the chemokine receptor gene cluster region. Two alternatively spliced transcript variants have been described. Multiple transcript variants encoding different isoforms have been found for this gene.

Gene names and symbols associated with CCR9

  • chemokine (C-C motif) receptor 9 (CCR9) antibody
  • atypical chemokine receptor 2 (Ackr2) antibody
  • atypical chemokine receptor 2 (ACKR2) antibody
  • chemokine (C-C motif) receptor 9 (Ccr9) antibody
  • A130091K22Rik antibody
  • AI464239 antibody
  • CC-CKR-9 antibody
  • CCBP2 antibody
  • CCR9 antibody
  • CCR10 antibody
  • CDw199 antibody
  • CMKBR9 antibody
  • Cmkbr10 antibody
  • D6 antibody
  • GPR-9-6 antibody
  • GPR28 antibody
  • hD6 antibody

Protein level used designations for CCR9

C-C chemokine receptor D6 , D6 beta-chemokine receptor , chemokine binding protein 2 , chemokine-binding protein 2 , chemokine-binding protein D6 , CC-chemokine-binding receptor JAB61 , chemokine (C-C motif) receptor 9 , chemokine (C-C) receptor 9 , chemokine receptor CCR-10 , chemokine receptor CCR-9 , chemokine receptor D6 , C-C chemokine receptor type 9 , G protein-coupled receptor 28 , C-C CKR-9 , CC-CKR-9 , CCR-9 , chemokine C-C receptor 10 , chemokine C-C motif receptor 9

100065535 Equus caballus
59289 Mus musculus
1238 Homo sapiens
10803 Homo sapiens
12769 Mus musculus
282832 Rattus norvegicus
484793 Canis lupus familiaris
530951 Bos taurus
678667 Ovis aries
Selected quality suppliers for Chemokine (C-C Motif) Receptor 9 (CCR9) ELISA Kits
Did you look for something else?